{
    "organizations": [],
    "uuid": "41677c978bd5dd11dc9fb30c12e5ab2be742524d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-yichang-hec-changjiang-pharmaceuti/brief-yichang-hec-changjiang-pharmaceutical-announces-china-fda-approval-for-esomeprazole-sodium-for-injection-idUSFWN1S41I1",
    "ord_in_thread": 0,
    "title": "BRIEF-Yichang Hec Changjiang Pharmaceutical Announces China FDA Approval For Esomeprazole Sodium For Injection",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 27 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co Ltd:\n* ESOMEPRAZOLE SODIUM FOR INJECTION 40MG & 20MG APPROVED BY CHINA FDA FOR LAUNCHING INTO MARKET Source text : [ bit.ly/2r5DdWX ] Further company coverage:\n ",
    "published": "2018-04-27T23:17:00.000+03:00",
    "crawled": "2018-04-28T13:09:05.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "yichang",
        "hec",
        "changjiang",
        "pharmaceutical",
        "co",
        "ltd",
        "esomeprazole",
        "sodium",
        "injection",
        "40mg",
        "20mg",
        "approved",
        "china",
        "fda",
        "launching",
        "market",
        "source",
        "text",
        "company",
        "coverage"
    ]
}